242 results on '"Jilma-Stohlawetz, Petra"'
Search Results
2. The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
3. Comparison Evaluation of Automated Nucleated Red Blood Cell Enumeration by Sysmex XN 1000 in Comparison With Microscopic Reference in Children Under 1 Year
4. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
5. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent
6. Regulation of histamine and diamine oxidase in patients undergoing orthotopic liver transplantation
7. A model comparing how rapidly transfusion of solvent detergent plasma restores clotting factors versus infusion of albumin-saline
8. D-dimer and histamine in early stage bacteremia: A prospective controlled cohort study
9. Upregulation of cytokine mRNA in circulating leukocytes during human endotoxemia
10. The use of frozen plasma samples in thromboelastometry
11. von Willebrand Factor-binding aptamer rondoraptivon pegol as treatment for severe and non-severe hemophilia A
12. False‐positive pregnancy test after transfusion of solvent/detergent‐treated plasma
13. The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
14. Androgen deprivation decreases prostate specific antigen in the absence of tumor: implications for interpretation of PSA results
15. Platelet glycoprotein Ibα polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease
16. Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers
17. Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers
18. Limitations of a calibrated, quantitative APC‐R assay under routine conditions
19. The aptamer ARC1779 blocks von Willebrand factor–dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo
20. Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact-R
21. Anti–von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura
22. In vitro platelet function of platelet concentrates prepared using three different apheresis devices determined by impedance and optical aggregometry
23. The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia
24. Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK
25. Platelet function under high-shear conditions from platelet concentrates
26. Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide
27. Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates
28. Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humans
29. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin
30. Effects of anticoagulation on thrombopoietin release during endotoxemia
31. Granulocyte colony-stimulating factor (G-CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans
32. Interference in specialized coagulation assays affecting the protein C pathway: Effects of marked haemolysis, hyperbilirubinaemia and lipaemia on chromogenic and clotting tests on two coagulation platforms
33. Limitations of a calibrated, quantitative APC‐R assay under routine conditions.
34. Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases
35. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia
36. Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing
37. Long Term Efficacy, Safety and PK/PD Profile of the Anti-C1s Antibody (BIVV009) in Primary Cold Agglutinin Disease Patients
38. Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM)
39. Colistin dampens fibrinolysis and endothelial activation during endotoxaemia
40. Lupus-anticoagulant testing at NOAC trough levels
41. Vox Sanguinis / The association of the Thr715Pro P-selectin genotype with levels of P-selectin in platelet concentrates
42. Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow
43. Morphine Decreases Clopidogrel Concentrations and Effects
44. Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent
45. Reversal Strategy For Antagonizing The P2Y12-Inhibitor Ticagrelor By Platelet Concentrates
46. Androgen deprivation decreases prostate specific antigen in the absence of tumor: implications for interpretation of PSA results
47. Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein phosphorylation to assess P2Y12-inhibition after ticagrelor intake
48. Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y12-inhibition after ticagrelor intake
49. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease
50. Effects of Strong P2Y12 Receptor Inhibition by Prasugrel on Platelet Inhibition During Endotoxemia: A Randomized Controlled Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.